Interview
1. What makes an article top quality?
Response: My response here differs in research articles compared to reviews. A top research article needs to address a compelling topic, and it needs to report entirely novel results. It is unusual for an article to meet both criteria. Reporting of novel results, however, is a requirement. If an article presents no novel observations, then no one will read it. Not all articles can address a compelling topic. In the field of virology, for example, a compelling topic would be something like: How does a virus cause disease? What is the immunological response to infection by a virus? Many published articles address topics that are less than compelling, and that is to be expected. Novelty, however, is required. Review articles are quite different. They are all about clarity. No new results are reported in most review articles, so the text needs to hold the reader’s attention without the attraction of novel findings. That means clarity and succinctness. Review articles need to cover a well-defined area of the literature and do so as briefly as possible. The text needs to be clear and constructed so that it holds the reader’s attention. Reviews need to include copious references to the relevant original papers.
2. Do you think that journals determine research trends?
Response: No. I think in most cases research priorities are determined by the funding agencies. Journals reflect research trends after they are already in place. There are exceptions to the above generalization. Some journals choose to publish only articles that represent a sub-set of the topics in a larger field. In this way they would determine research trends to some extent. My experience, however, is that most journals reflect research priorities determined by others.
3. What makes a good position paper?
Response: I am not sure I know what a position paper is. I have never written one or read one.
4. What are the qualities you look for in an article?
Response: Clarity of presentation is my first priority. If I cannot understand the problem the authors are trying to solve or how they are going about it, then I usually do not read any further. My second priority is the degree I am convinced by the authors’ results. Appropriate control experiments need to be done, and I need to be convinced the controls are actually appropriate. Finally, the authors’ interpretations need to accurately describe the meaning of the results. Important results will not have any impact if they are not interpreted in a convincing way. Interpretation of the authors’ results will usually include a description of how the results have moved the field forward.
5. Can you give us a broad indication of the types of themes a scientific journal should cover?
Response: Journals have a unique role to report novel scientific findings. No other medium of communication fulfills this role. A new finding is reported and validated when it is published in a journal. Journals therefore will be attracted to the areas of research that are currently most active. I believe that is appropriate. People are attracted to read journal articles when they want to know the latest results in the most fast-moving fields of science. Currently active fields can usually be identified by attending a conference in the relevant area. Articles published in Science and Nature are a good guide to the content of currently active fields of research.
6. What sorts of research methods and frameworks do you expect people to use, and how will they balance conceptual and applied research?
Response: The methods used in a scientific study need to be appropriate for the measurements to be made. That’s really all that needs to be said here. Use of appropriate methods is a part of what makes a scientific study convincing. It is true, however, that scientific progress often follows and depends on development of novel methods. There is clearly an important place in scientific publishing for the description and use of novel methods. These need to be considered and evaluated like other aspects of a submitted manuscript.
7. How would you describe the journal’s mission and editorial objectives to our readers?
Response: I would say that we cover all aspects of virology with an emphasis on applications for vaccine development and identification of small molecule inhibitors of virus replication.
8. If you could be granted dream articles, what would they be on?
Response: I would like to see papers that describe the identification of small molecule inhibitors of virus replication or novel methods to identify small molecule inhibitors.
9. Are there any particular areas which you would like to see, or expect to see, collaborate?
Response: I would like to continue to see the use of viruses in gene therapy and use of viruses in the field of nanoscience and nanotechnology.
10. How does the research published percolate through to practitioners?
Response: My experience is that transmission to practitioners (e.g. those in pharmaceutical companies) usually occurs by word of mouth. Conferences are great places for this to occur. Investigators and practitioners are both present at the best conferences, and productive exchange of ideas takes place easily and on a large scale.
11. How can a publisher ensure the authors/readers a rigorous peer review and quality control?
Response: That’s tricky. It depends on having a personal relationship with prospective reviewers and editors. Reviewers are busy people and do not get paid for their reviewing activities. Their reward depends on the opportunity to learn about novel findings in their fields. It helps if a prospective reviewer is a personal friend or colleague of the editor.
12. Your editorial policy is to be eclectic and welcome perspectives from other disciplines and schools. How does this translate into the types of contributions you encourage?
Response: I try to encourage all kinds of contributions. JVA needs as many quality papers as possible. I try to encourage anything that is relevant in content.
13. What do you see as the merits of journals, as opposed to book series, as a means of scholarly communications?
Response: Journals are of central importance because of their role in identifying and communicating novel findings. Books don’t do that. No other medium does. People look to journals for access to the latest findings. Books are similar to review articles in that they organize pre-existing knowledge. New findings are reported in journals.
14. How do you differentiate Journal of Virology & Antiviral Research with other journals in the field?
Response: JVA necessarily covers much of the same territory as other journals in the field of virology. I feel it stands out because of its ability to emphasize vaccinology and development of small molecule therapeutics.
Publications
-
Histological Phenotype of Breast Cancer in Indigenous Malawian Women Presenting at Queen Elizabeth Central Hospital in Malawi
Research Article: J Virol Antivir Res 2017, 6:1
DOI: 10.4172/2324-8955.1000164
Nelson Chimbiya, Clemence Marimo , Trevor Kaile, Tamiwe Tomoka, Steve Kamiza , Fabian Chapima and Marah Simakando
-
Infective Agent Medical Specialty and Infective Agent Infections
Short Communication: J Virol Antivir Res
DOI: 10.37532/2324-8955.2020.9(3)201
Mounica Merihelan*
-
Virology to Study Clinical Patterns of Viral Respiratory Infections
Perspective: J Virol Antivir Res
DOI:
Yingying Wang
-
Short Note on Infectious Agent Fever and Symptoms and Interference of Infectious Agent Fever
Short Communication: J Virol Antivir Res
DOI: 10.37532/2324-8955.2020.9(3)202
Mounica Merihelan*
-
Met genomic Next-Generation Sequencing in Clinical Virology
Perspective: J Virol Antivir Res
DOI:
Milkiyas Moru
-
Viruses and Viruses Unfolding by Coughing and Symptom
Short Communication: J Virol Antivir Res
DOI: 10.37532/2324-8955.2020.9(3)203
Mounica Merihelan*
-
Virological Assessment Of Confirmed Human Monkey pox Virus
Commentary: J Virol Antivir Res
DOI:
Zongcai Tu
-
Structure and Genome Discovery of HIV Virus and Development of HIV-Protease Inhibitors
Perspective: J Virol Antivir Res 2021, 10: (6)
DOI:
Aegeus Chloros
-
Virological and Clinical Outcomes in Outpatients Treated
Commentary: J Virol Antivir Res
DOI:
Mostafa Alsenani
-
Human Endogenous and Exogenous Retroviruses and clinical Manifestations
Short Communication: J Virol Antivir Res 2021, 10: (6)
DOI:
Adam Cohen
-
Clinical and Virological Characteristics of Patients during Outbreak
Opinion Article: J Virol Antivir Res
DOI:
Richard Chiavacci
-
Viral Proteomics: Worldwide Assessment of Infections and their Interaction
Commentary: J Virol Antivir Res 2021, 10: (6)
DOI:
Qiang Cheung
-
Entry of Hepatitis B Virus: Innovatory Treatment and their Antiviral Targets
Opinion Article: J Virol Antivir Res 2021, 10: (6)
DOI:
Asahi Ito
-
Virtual Screening Reveals Potential Anti-Parasitic Drugs Inhibiting the Receptor Binding Domain of SARS-CoV-2 Spike protein
Research Article: J Virol Antivir Res 2021, 10: (4)
DOI:
Sathya Muthusamy, Hariprabu Gopal, Thiliban Manivarma, Satya Narayan Pradhan, Prince. R. Prabhu*
-
In vivo activity of pyrimidine-dispirotripiperaziniumin in the male guinea pig model of genital herpes
Research Article: JVA
DOI: DOI: 10.37532/jva.2020.9(1).193
Novoselova EA1*, Alimbarova LM3, Monakhova NS1, Lepioshkin
AY1, Ekins S2 and Makarov VA1
-
Estimation of the Role of Apolipoprotein E Genotypes in Patient Infected with Hepatitis C Virus and Treatment with Sovaldi Drug
Research Article: J Virol Antivir Res 2019, 8:1
DOI:
El-Adly AM, Rashed LA, Yehia HM, Wardany AA, Shikhoun MH and Abdul-Raouf UM
-
Why is Delta so Dangerous? How Coronavirus Attacks Cells
Perspective: J Virol Antivir Res 2021, 10: (5)
DOI:
Qiang Cheung
-
Causes of Yellow Fever Spread
Short Communication: J Virol Antivir Res 2021, 10: (3)
DOI:
Charlotte Martin *
-
Human Retroviral Infections in Viral Genome Organization
Perspective: J Virol Antivir Res 2021, 10: (5)
DOI:
Jason Garcia*
-
Impact of Corona Virus on Mental Health
Commentary: J Virol Antivir Res 2021, 10: (3)
DOI:
Guanghui Deng
-
Viral Threats in Aquaculture: The Battle Continues
Editorial: J Virol Antivir Res 2015, 4:1
DOI: 10.4172/2324-8955.1000e107
J M Grijalva-Chon and R Castro Longoria
-
Review of Ebola Virus in Africa
Perspective: J Virol Antivir Res 2021, 10: (3)
DOI:
Kristian Andersen
-
Role of Interleukin-10, Interleukin-12 in the Response Prediction during Combined PEG Interferon-alpha 2a and Ribavirin Therapy in Patients with Chronic Hepatitis C
Research Article: J Virol Antivir Res 2015, 4:1
DOI: 10.4172/2324-8955.1000134
Amal Ahmed Mohamed*, Marwa M E Abd Elmonsef, Marwa K. Darwish , Mohamed A Atallah, Mohamed Ezz, Said El-Feky and Heba Ebrahim
-
Viral Respiratory Infection Pathogenesis
Opinion Article: J Virol Antivir Res 2021, 10: (3)
DOI:
Sarah Lebeer
-
Longitudinal Analysis of Cerebrospinal Fluid and Plasma HIV-1 Envelope Sequences Isolated From a Single Donor with HIV Asymptomatic Neurocognitive Impairment
Research Article: J Virol Antivir Res 2015, 4:1
DOI: 10.4172/2324-8955.1000135
Fabian Vazquez-Santiago, Yashira Garcia, Ivelisse Rivera- Roman, Richard J Noel Jr , Valerie Wojna, Loyda M Melendez and Vanessa Rivera-Amill
-
A Brief Note on Virus Infections and Interferons
Rapid Communication: J Virol Antivir Res 2021, 10: (3)
DOI:
Hossein Bannazadeh Baghi
-
Influence of HIV-1 Genetic Variability on Vertical Transmission and Pathogenesis
Review Article: J Virol Antivir Res 2015, 4:1
DOI: 10.4172/2324-8955.1000136
Nafees Ahmad
-
Ebola Virus Disease
Perspective: J Virol Antivir Res
DOI: 10.37532/jva.2021.10(1).204
Lakshmi vasudha Yerrinki *
-
Virotherapy: Brief Overview
Short Communication: J Virol Antivir Res
DOI: 10.37532/jva.2021.10(1).205
Akhila Sabbineni*
-
Human Immunodeficiency Virus
Opinion Article: J Virol Antivir Res
DOI: 10.37532/jva.2021.10(1).206
Gowthami Bainaboina
-
RNA Interference Technique
Commentary: J Virol Antivir Res
DOI: 10.37532/jva.2021.10(1).207
Bharathi Bhusurapalli
-
Antiviral Techniques
Perspective: J Virol Antivir Res
DOI: 10.37532/jva.2021.10(1).208
Ramya Chiyyadri *
-
Bacterial Diseases 2020- To Knowledgeable and Scintillating Presentation
2020 Conference Announcement: J Virol Antivir Res 2019, 8:2
DOI:
Robert O Young
-
Young Researchers Forum - Young Scientist Awards Virology Congress 2020
Young Research Forum: J Virol Antivir Res 2019, 8:2
DOI:
Alejandro De La Parra Solomon
-
Young Researchers Forum - Young Scientist Awards Bacterial Diseases 2020
Young Research Forum: J Virol Antivir Res
DOI:
Robert O Young
-
Awards for Microbiology 2020: Take the first step in the Microbiological world
Awards 2020: J Virol Antivir Res
DOI:
Tony Velkov
-
Microbiology 2020: Take first step in the Microbiological World
Market Analysis: J Virol Antivir Res
DOI:
Tony Velkov
-
12th International Virology Summit
2020 Conference Announcement: J Virol Antivir Res 2019, 8:2
DOI:
Vsevolod A Zinserling
-
12th International Virology Summit
Young Research Forum: J Virol Antivir Res 2019, 8:2
DOI:
Vsevolod A Zinserling
-
Young Scientist Awards: Virology Asia 2020
Young Research Forum: J Virol Antivir Res 2019, 8:2
DOI:
Indranil Banerjee
-
2020 Conference Announcement on 15th International Conference on Virology, Emerging Diseases & Vaccines
Past Conference Report: J Virol Antivir Res 2019, 8:2
DOI:
Giulio Filippo Tarro
-
Young Researchers Forum - Young Scientist Awards {Virology 2020}
Young Research Forum: J Virol Antivir Res
DOI:
Giulio Filippo Tarro
-
Do ABO and Rhesus Blood Groups Affect Susceptibility to, and Prognosis of Ebola Virus Infection?
Short Communication: J Virol Antivir Res 2017, 6:1
DOI: 10.4172/2324-8955.1000165
Brian Conton, Sahr Gevao, Foday Sahr, Osman Kargbo, Philip Kamara, Abdulai Bah, Thomas Massaquoi, Baimba Idriss, Foday Sesay, Adeshola Williams, Samuel Baker, Sylvester Nicol and James B Russell
-
Annual Summit on Infectious Disease & Healthcare
2020 Conference Announcement: J Virol Antivir Res 2019, 8:2
DOI:
Suresh Vatsyayann
-
Young Research Forum - Young Scientist Awards: Antibiotics: Discovery & Development
Young Research Forum: J Virol Antivir Res 2019, 8:2
DOI:
Alice Genyi
-
International Conference on Traditional Chinese Medicine and Acupucture
2020 Conference Announcement: J Regen MedJ Virol Antivir Res 2019, 8:2
DOI:
Milagrosa Chiu Shieh Li
-
Traditional Chinese Medicine and Acupuncture
Young Research Forum: J Regen Med
DOI:
Milagrosa Chiu Shieh Li
-
Examination of Infection Parameters for Replication of Israeli Isolate of Koi Herpesvirus in Common Carp Brain Cells
Research Article: J Virol Antivir Res 2017, 6:3
DOI: 10.4172/2324-8955.1000176
Lisa Katharina Jordan, Anette Amtmann, Elke Heidenreich, Jürgen Christian, Rainer Buchholz, Anna Maria Becker
-
International Conference on Traditional Chinese Medicine and Acupucture
Awards 2020: J Virol Antivir Res 2019, 8:2
DOI:
Milagrosa Chiu Shieh Li
-
International Congress on Traditional and Natural Medicines
2020 Conference Announcement: J Virol Antivir Res 2019, 8:2
DOI:
Kazuko Tatsumura
-
Broadly Neutralizing Antibodies between HIV Vaccination and Treatment the Beginning of the End?
Review Article: J Virol Antivir Res 2018, 7:2
DOI: 10.4172/2324-8955.1000183
Mohannad Naser, Hebatullah Hassan, Nada Hisham and Manal Baddour*
-
Seroprevalence of Chikungunya during Outbreak in Dhaka, Bangladesh in 2017
Research Article: J Virol Antivir Res 2018, 7:2
DOI: 10.4172/2324-8955.1000184
Rashid MDHO, Patwary MH,Imtiaz A,Abdullah SA,Zahedur R,Ibrahim K and Zzaman Md T
-
Genetic Diversity in Viral Populations
Perspective: J Virol Antivir Res
DOI:
Jang Dinu
-
An Overview of Risk Factors of Vertical Transmission of Hepatitis C Virus and Treatment Options for Chronic HCV
Review Article: J Virol Antivir Res 2018, 7:2
DOI: 10.4172/2324-8955.1000185
Arsenaki E and Christina B
-
Novel Viral Proteomics Techniques and Discoveries
Short Communication: J Virol Antivir Res
DOI:
Olivin Roosar
-
Precise Gene Manipulation Using RNA Interference
Perspective: J Virol Antivir Res
DOI:
Tamang Logan
-
IL28B is An Irrelevant Prognostic Factor for HCV in the Era of Highly Effective DAAs
Research Article: J Virol Antivir Res 2018, 7:2
DOI: 10.4172/2324-8955.1000186
Asraf Hussain Hashmi, Mehmood Ahmed Husnain, Amjad Farooq, Kashaf Khalid, Sobia Shafique, Khaqan Adeel, Syed Ali Raza Kazmi and Abdul Rauf Shakoori
-
The Potential of Host Defenses: Mechanisms and its Effects
Opinion Article: J Virol Antivir Res
DOI:
Roonei Cooter
-
Viral Therapy Advances for Treating Diseases
Opinion Article: J Virol Antivir Res
DOI:
Jong Dejian
-
First Identification of Orungo Virus (Orbivirus) from a Febrile Patient in South-Eastern Senegal, 2015
Research Article: J Virol Antivir Res 2018, 7:2
DOI: 10.4172/2324-8955.1000187
Martin Faye, Arame Ba, Yakhouba Kane, Andre Pouedewou Bedekelabou, Mamadou Diop, Moussa Moise Diagne, Gamou Fall, Oumar Faye, Amadou Alpha Sall and Ousmane Faye
-
Young Researchers Forum - Young Scientist Awards {Virology Congress 2020 }
Young Research Forum: J Virol Antivir Res 2019, 8:2
DOI:
Alejandro De La Parra Solomon
-
Annual Summit on Infectious Disease & Healthcare
Market Analysis: J Virol Antivir Res 2019, 8:2
DOI:
Suresh Vatsyayann
-
Increased Serum Kynurenine Level is Associated with Severity of Kidney Injury in Puumala Hantavirus Infection
Research Article: J Virol Antivir Res 2014, 3:4
DOI: 10.4172/2324-8955.1000130
Mahmoud Sadeghi, Imad Lahdou, Stefan Mehrle, MojdehHeidary Navid, Volker Daniel, Martin Zeier, Paul Schnitzler, Gerhard Opelz and Peter Terness
-
Basant, a Polyherbal Topical Microbicide Candidate Inhibits different Clades of Both CCR5 and CXCR4 Tropic, Lab-Adapted and Primary Isolates of Human Immunodeficiency Virus-1 in Vitro Infection
Research Article: J Virol Antivir Res 2014, 3:4
DOI: 10.4172/2324-8955.1000131
Maciej B Maselko, Rupali S Joshi,Meagan Prescott, GP Talwar, Smita Kulkarni, Manoj K.Pastey
-
A Randomized Clinical Trial of Pegylated Interferon for Acute Hepatitis C Virus Infection in Active Injection Drug Users
Research Article: J Virol Antivir Res 2014, 3:4
DOI: 10.4172/2324-8955.1000132
Erica Coppel ,Meighan Krows ,Misty Saracino , Linda Cook ,Ka Wing Sullivan ,Jason Veitengruber3,Holly Hagan ,Hanne Thiede ,Anna Wald, Chia C Wang
-
Twice Daily Dosing of Telaprevir for Treatment-Naive and Treatment-Experienced Patients with Hepatitis C Infection
Research Article: J Virol Antivir Res 2014, 3:4
DOI: 10.4172/2324-8955.1000133
David M You, Douglas Hunt, Michael W Fried, David R Nelson, Andrea Scherschel , Bryan Still2 , Paul J Pockros
-
Control of Host Gene Expression by a Herpesvirus Transcription Factor
Research Article: J Virol Antivir Res
DOI: 10.4172/2324-8955.1000140
Jay C Brown
-
Occurrence of Escape Favoring Mutations in The Targets of 2F5 and 4E10 Antibodies of HIVgp41 : A Metadata Analysis
Research Article: J Virol Antivir Res
DOI: 10.4172/2324-8955.1000141
Christdas J and Shakila H
-
Prevalence of Viral Hepatitis B and C Markers in Multitransfused Patients with Chronic Kidney DiseaseCompared with The General Population in Albania
Research Article: J Virol Antivir Res
DOI: 10.4172/2324-8955.1000142
Tatjana Nurka, Erika Ebranati, Robert Cina, Zhaneta Abazi ,Anila Kristo , Xhensila Frasheri , Vjollca Shpata , Pranvera Dragusha , Massimo Ciccozzi , Gianguglielmo Zehender and Renata Shkjezi
-
A Quiet Pandemic: Crimean-Congo Haemorrhagic Fever
Perspective: J Virol Antivir
DOI:
Vorica Heimann
-
HIV and the Immune System: A Struggle of Complexity and Resilience
Opinion Article: J Virol Antivir
DOI:
Serena Lellinge
-
Monkey Fever: Understanding Kyasanur Forest Disease
Perspective: J Virol Antivir
DOI:
Devendra Univenkappa
-
Severe Acute Respiratory Syndrome Affected by COVID-19
Perspective: J Virol Antivir Res 2021, 10: (4)
DOI:
John Miller
-
Understanding the Complex Anatomy of the H1N1 Influenza Virus
Short Communication: J Virol Antivir
DOI:
Madelon Alauring
-
The Dual Role of Antivirals and Vaccines in Treatment and Prevention
Commentary: J Virol Antivir
DOI:
Kyoko Iworimoto
-
The Remarkable Rise in Use of Viruses in Potential Medicine
Perspective: J Virol Antivir
DOI:
Sergi Leserno
-
Synthesis of Phosphorimidate Derivatives of Acyclovir with Antiviral Activity in Vitro
Commentary: J Virol Antivir Res
DOI:
Payal M Oak
-
An Analysis of HIV-Infected Patients Attending an Urban Teaching Hospital in Kenya and their Antiretroviral Therapy Change
Opinion Article: J Virol Antivir Res
DOI:
AO Owuor
-
HIV Co-Infected with Covid-19 Patients with Antibody Responses to Sars-Cov-2
Perspective: J Virol Antivir Res
DOI:
Rumpa Saha
-
Children with HIV Receiving Oral Health Care
Perspective: J Virol Antivir Res
DOI:
Gerardo Rivera Silva
-
Genome sequencing, Analysis and Characterization of Baculovirus Infecting the Caterpillar, Spilosoma Obliqua Walker (Arctiidae) (Insecta: Lepidoptera) from India
Research Article: J Virol Antivir Res 10: 5
DOI:
Sayan Paul1,2, Subburathinam Balakrishnan1 , Arun Arumugaperumal1 , Emmanuel Joshua Jebasingh Sathiya Balasingh Thangapandi1 , Huidrom Sarjubala Devi3 , Thang Johnson3 , Shyam Maisnam3 , Sandhya Soman Syamala1 , Ramamoorthy Sivakumar4 , Raman Karthikeyan4 , Chandramohan Subburaman5 , Sathyalakshmi Alaguponniah6 , Deepa Velayudhan Krishna6 , Kris
-
The Role of Emerging Tools Used in COVID-19 in India
Research Article: J Virol Antivir Res 2021, 10: (5)
DOI:
Rinka Juneja, Anil Ahuja and Vishal M. Balaramnavar*
-
Antiviral Drug Monitoring: Paving the Path to Precision Medicine in Viral Infections
Perspective: J Virol Antivir
DOI:
Ismail Akhtar
-
Advancing Antiviral Therapies and Understanding Immune Responses
Opinion Article: J Virol Antivir
DOI:
Chao Wang
-
Broad-Spectrum Antivirals: Paving the Way for Pandemic Preparedness
Opinion Article: J Virol Antivir
DOI:
Mathieu Tropsha
-
Exploring the Complex Nexus: HIV and the Central Nervous System
Perspective: J Virol Antivir
DOI:
Lacy Schaeffer
-
The Intricacies of Host-Virus Interaction: Implications for Health and Disease
Short Communication: J Virol Antivir
DOI:
Arif Alabdallah
-
Unravelling the Power of Innate Immune Responses to Viral Infections: Safeguarding Our Health from the Outset
Opinion Article: J Virol Antivir
DOI:
Fang Fangchao
-
Short Note on Hepatitis
Short Communication: J Virol Antivir Res
DOI: 10.37532/jva.2020.9(2)197
Mounica Merihelan
-
Converging Paths: Unraveling the Link between Non-Alcoholic Fatty Liver Disease (NAFLD), Viral Hepatitis, and Potential Therapeutic Synergy
Perspective: J Virol Antivir
DOI:
Esteban Herbert
-
Short Note on HIV and AIDS
Short Communication: J Virol Antivir Res
DOI: 10.37532/jva.2020.9(2).198
Mounica Merihelan
-
RNA Interference (RNAi) Therapies for Rare Genetic Disorders: A Promising Frontier in Precision Medicine
Commentary: J Virol Antivir
DOI:
Lanier Corbin
-
Seroprevalence of SARS-CoV-2 IgG Antibodies among PostInfection COVID-19 Patients and Post Vaccination at a Tertiary Care Hospital
Research Article: J Virol Antivir Res 2021, 10: (5)
DOI:
Sidra Sadiq1 *, Maria Khan2 , Tayyaba Sadiq3 , Mirza Muhammad Dawood Ramin1 , and Najeeb Ul Haq3
-
Viral Proteomics: Decoding the Intricate World of Viral Proteins
Opinion Article: J Virol Antivir
DOI:
Stephan Phillips
-
Isolation and Identification of Enteroviruses from Sewage and Sewage-Contaminated Water Samples from Ibadan, Nigeria, 2012-2013
Research Article: J Virol Antivir Res 2017, 6:3
DOI: 10.4172/2324-8955.1000177
Johnson Adekunle Adeniji, Adetunji Oladapo Adewale, Temitope Oluwasegun Cephas Faleye and Moses Olubusuyi Adewumi
-
The Role of Viral Shedding in Disease Transmission
Opinion Article: J Virol Antivir
DOI:
Norifumi Suto
-
Editorial Note on Antiviral Drugs
Editorial: J Virol Antivir Res
DOI: 10.37532/jva.2020.9(2).e196
Mounica Merihelan
-
Bacteriophages Benefits and Drawbacks in the Treatment of Bacterial Infections
Short Communication: J Virol Antivir Res 2021, 10: (4)
DOI:
Matheus Silva*
-
A Brief Overview of Porcine Enteric Diarrhoea Virus
Opinion Article: J Virol Antivir Res 2021, 10: (4)
DOI:
Chen Huang*
-
Gastro-intestinal Involvement of Primary Varicella Zoster Virus Infection in a Renal Transplant Recipient
Research Article: J Virol Antivir Res 2014, 3:3
DOI: 10.4172/2324-8955.1000126
M.M.L. Kho , I. Noorlander , W. Weimar, M. van Agteren ,G.M.G.M. Verjans , R.M. Verdijk , A.A. van der Eij and N.M. van Besouw
-
Study of HIV-1 Co-receptor Tropism and Resistance to Integrase Strand Transfer Inhibitors in the Indian Patients for Inducting New Antiretroviral Drugs in Treatment Regimens Recipient
Research Article: J Virol Antivir Res 2014, 3:3
DOI: 10.4172/2324-8955.1000127
Pratiksha Chheda, Shamma Shetye , Priyanka Andrade and Nilesh Shah
-
Pilot Study of Epstein Barr virus Infection at the Onset of Acute Lymphoblastic Leukaemia in Egyptian Children
Research Article: J Virol Antivir Res 2014, 3:3
DOI: 10.4172/2324-8955.1000128
Maysaa El Sayed Zaki , Walaa Othman El Shabrawy and Rasha Elashry
-
Vitamin D Metabolites Inhibit Hepatitis C Virus and Modulate Cellular Gene Expression
Research Article: J Virol Antivir Res 2014, 3:3
DOI: 10.4172/2324-8955.1000129
Julio A. Gutierrez , Krysten A. Jones , Roxana Flores , AkulSinghania, Christopher H. Woelk, Robert T. Schooley ,and David L. Wyles
-
Hepatitis A:An Brief Overview
Short Communication: J Virol Antivir Res 2019, 8: (1)
DOI:
sai sree kolluri
-
Concentrates from Aframomium melegueta K. Schum and Vernonia amygdalina Delile Inhibit Proliferation of Atypical Fowl Pox Virus in Embryonated Chick Eggs (Eces)
Research Article: J Virol Antivir Res 2019, 8:1
DOI:
Afolami OI, Oladunmoye MK, Chukwuedo AA, Asala OO, Nwagbo IO, Oladejo BO, Abe TO, Akpa AR, Aribisala JO and Owoyemi OO
-
Immunological and Virological Effects of Novel Prakasine Nanomedicine in HIV-Infected Patients in South India: A Preliminary Study
Research Article: J Virol Antivir Res
DOI: 10.37532/jva.2020.9(2).195
Prakash S.K
-
Evaluation of N Gene, S Gene and ORF Based Real-Time RTPCR Assays by Taqpathcovid 19 Combo Kit for Confirmationof SARS-Cov-2 Infection: An Observational Study
Opinion Article: J Virol Antivir Res 2021, 10: (6)
DOI:
Jyoti Khurana*1 , Sulekha Yadav1 , Suman Kumar1 , Anita Mutha2 , Manish Purohit3 , Thang Sunil Ahirwar
-
Comparative Sensitivity of LFBK and LFBK αVβ6 Cell Lines for Isolation of Foot and Mouth Disease Virus from Riverine Buffaloes by Using Oro-Pharyngeal Fluids
Research Article: J Virol Antivir Res 2019, 8:1
DOI:
Ali A, Zahur AB, Farooq U, Latif A, Naeem K, Afzal M, Ullah RW, Shabana and Muhammad ZY
-
Molecular Detection of Human Papilloma Virus Infection of Uterine Cervix among Women of Reproductive Age
Research Article: J Virol Antivir Res 2019, 8:1
DOI:
Misbah Noor, Eijaz Ghani, Saifullah Khan Niazi and Muhammad Tahir Khadim
-
Concentrates from Aframomium melegueta K. Schum and Vernonia amygdalina Delile Inhibit Proliferation of Atypical Fowl Pox Virus in Embryonated Chick Eggs (Eces)
Research Article: J Virol Antivir Res 2019, 8:1
DOI:
Afolami OI, Oladunmoye MK, Chukwuedo AA, Asala OO, Nwagbo IO, Oladejo BO, Abe TO, Akpa AR, Aribisala JO and Owoyemi OO
-
Molecular Analysis of HCV Real Time PCR in Multan Pakistan
Research Article: J Virol Antivir Res 2021, 10: (4)
DOI:
Muhammad Waqar Mazhar1*
-
The Science of Viral Diseases and Their Impact on Health
Short Communication: J Virol Antivir Res
DOI:
Jianguo Hasan
-
The Lipid Rafts in Caprine herpesvirus type 1: Preliminary Study on Viral Infection in vitro
Editorial: J Virol Antivir Res 2017, 6:3
DOI: 10.4172/2324-8955.1000e109
Francesco Cirone and Annamaria Pratelli
-
Development of Echovirus 29 Cytopathology in RD Cell Line Might not Happen within 10 Days Post Inoculation
Short Communication: J Virol Antivir Res 2017, 6:3
DOI: 10.4172/2324-8955.1000175
Moses Olubusuyi Adewumi, Temitope Oluwasegun Cephas Faleye, Olaitan Titilola Ayinde, Ukeme Ibanga Ibok and Johnson Adekunle Adeniji
-
A Brief Note on Viral Genetics
Perspective: J Virol Antivir Res 2021, 10: (2)
DOI:
Azra Tabassum*
-
New Frontiers in Anti-Viral Research
Perspective: J Virol Antivir Res
DOI:
Nerea Montagnani
-
Profiles of Hepatitis B Virus Serological Markers among Asymptomatic Population in Anambra State, Southeastern Nigeria
Research Article: J Virol Antivir Res 2017, 6:3
DOI: 10.4172/2324-8955.1000174
Bakarey AS, Ifeorah IM, Adewumi MO, Faleye TOC, Akere A, Omoruyi EC, Ogunwale AO, Uttah CC, Oketade MA and Adeniji JA
-
Different Types of Hepatitis their Transmission and Prevention
Opinion Article: J Virol Antivir Res
DOI:
Crabb Hoepelman
-
Advancements in Viral Vector Technology for Gene Therapy
Opinion Article: J Virol Antivir Res
DOI:
Edar Agirre Beitia
-
Current Advances and Challenges in Clinical Virology
Opinion Article: J Virol Antivir Res
DOI:
Mercier Bogers
-
Coronaviruses: A Mini Review on the Emerging Pathogens
Expert Review: J Virol Antivir Res 2021, 10: (2)
DOI:
Arsalan Rasheed* and Tahir Usman
-
Hepatitis E Viral Infection in Pregnant Ladies, a Challenge for Obstetricians and Physicians
Research Article: J Virol Antivir Res 2021, 10: (2)
DOI:
Samia Jamil, Mahliqa Maqsud, Mehwish Ayyaz,Tayyaba Kanwal, Hafiz Muhammad Sajid Jehangir, Hamza Naeem, Samar Firdous and Sarmad Zahoor*
-
Isolation and Characterization of Bacteriophages from Wastewater Sources on Enterococcus spp. Isolated from Clinical Samples
Research Article: J Virol Antivir Res 2021, 10: (2)
DOI:
Yara Elahi, Jamileh Norouzi and Ramin Mazaheri Nezhad Fard*
-
An in vitro and in silico Antiviral Evaluation on Phytochemicals from the Leaves of Punica granatum L., and Punicalagin Against Human Herpes Virus-3
Research Article: J Virol Antivir Res 2021, 10: (2)
DOI:
Divyadarshini Angamuthua, Rajarajan Swaminathanb* and Indu Purushothamana
-
HIV Gp120 Sequence Variability Associated with HAND in Hispanic Women
Research Article: J Virol Antivir Res 2015
DOI: 10.4172/2324-8955.1000143
Krystal Colon, Fabian Vazquez-Santiago, Vanessa Rivera-Amill, Gisela Delgado, Steven E Massey, Valerie Wojna,Richard J Noel Jr and Loyda M Melendez
-
Seroprevalence, Immunostatus and Factors Associated with Blood Borne Viral Infections Among Egyptian Municipal Solid Waste Workers
Research Article: J Virol Antivir Res
DOI: 10.4172/2324-8955.1000144
Ekram W Abd El- Wahab, Safaa M Eassa, Sameh E Lotfi, Amira M Kotkat, Hanan Z Shatat and Sanaa A El Masry
-
Two Isolates of Potato Virus Y (PVY) and the Response of Different Potato Cultivars Against the Viral Infection
Research Article: J Virol Antivir Res
DOI: 10.4172/2324-8955.1000145
Dalia Gamil Aseel, Azaa Makhlouf, Sanaa A Riad, Elmorsi AA, GI Fegla and Hafez EE
-
The Influence of Porcine Reproductive and Respiratory Syndrome Virus Infection on the Expression of Cellular Prion Protein in Marc-145 Cells
Research Article: J Virol Antivir Res
DOI: 10.4172/2324-8955.1000146
Chongxu Shi, Yaozhong Ding, Xiaoyuan Ma, Yali Liu, Yunwen Ou, Bing Ma, Alexei D Zaberezhny, Zygmunt Pejsak, Anna Szczotka-Bochniarz, Yongguang Zhang and Jie Zhang
-
A Steady State Solution Method for HIV/AIDS Model for the Assesment, Monitoring, Control and Evaluation of Confirmed Status with Vertical Transmission in Nigeria
Research Article: J Virol Antivir Res 2017, 6:1
DOI: 10.4172/2324-8955.1000166
Capt (NN) MO Oladejo and Ali Onuche John
-
Understanding the Complex Relationship between the Human Pathogen Hantavirus and its Rodent Reservoirs Underpins a Rational Disease Control Strategy
Commentary: J Virol Antivir Res
DOI: 10.4172/2324-8955.1000147
Abdullah Mahmud-Al-Rafat, Mahbub-E-Sobhani and Andrew W Taylor-Robinson
-
CMV Infection in Atypical Hemolytic Uremic Syndrome
Case Report: J Virol Antivir Res 2017, 6:1
DOI: 10.4172/2324-8955.1000167
Can Hüzmeli, Hatice Terzi, Ferhan Candan, Ayye KekerKockara, Esin Yildiz and Mansur Kayatas
-
In-vitro Antiviral Activity of ZingiVir-H, a Novel Herbomineral Drug against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Research Article: J Virol Antivir Res
DOI:
Hareendran Nair J and Shan Sasidharan*
-
Histological Characterization of Invasive Cervical Cancer and Precursor Lesions in Malawian Women Presenting at Queen Elizabeth Central Hospital (QECH): A Cross-Sectional Study
Research Article: J Virol Antivir Res 2017, 6:1
DOI: 10.4172/2324-8955.1000168
Fred Fredrick Bangara, Clemence Marimo, Trevor Kaile, Marah Simakando, Tamiwe Tomoka, Gani Arabi, Limbikani Kanyenda, Christopher Newton Phiri and Steward Mudenda
-
Molecular Assays for the Detection of COVID-19 and Future Prospects
Perspective: J Virol Antivir Res
DOI:
Aynias Seid*
-
Evaluation of Mutagenicity of Covid-19 Virus and the Effect of Morphine in its Treatment
Opinion Article: J Virol Antivir Res
DOI:
Ali Khanifar *
-
Clinical Characteristics and Prognostic Factors of Hepatocellular Carcinoma in HIV-Infected Patients
Opinion Article: J Virol Antivir Res
DOI:
Juan Berenguer*
-
Past Conference Editorial of Euro Virology 2020
Editorial: J Virol Antivir Res
DOI:
Vsevolod A Zinserling
-
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
Annual Meeting Abstract: J Virol Antivir Res
DOI:
Ciro Celsa
-
Virus-Induced FOXO Protein Facilitates Viral Replication of Human Cytomegalovirus
Annual Meeting Abstract: J Virol Antivir Res
DOI:
Sirwan Sleman
-
Emerging COVID-19: Brief Focus on its Zoonotic Potential and Prevention
Editorial: J Virol Antivir Res
DOI:
Bayissa Chala*
-
Problematic issues of pathology of a new coronavirus infection COVID-19
Annual Meeting Abstract: J Virol Antivir Res
DOI:
Vsevolod A Zinserling
-
Development of SARS-CoV-2 Circulating Immune Complex Candidate, (CRCX) as a New Promising Vaccine Eliciting Broad Immune Response, Alternative to Conventional Vaccine with Potent Protection against SARS-CoV-2
Research Article: J Virol Antivir Res
DOI:
Salah Sherif1*, Mubarki Abdula2, Fahmy Walid3, Ghaleb Heider4 and Hamed Ehab5
-
Molecular diagnosis of hepatitis C untypeable genotypes among chronically infected patients in Pakistan
Annual Meeting Abstract: J Virol Antivir Res
DOI:
Shahroz Khan
-
Virome of children with acute gastroenteritis identified a novel human adenovirus C type with a chimeric hexon gene
Annual Meeting Abstract: J Virol Antivir Res
DOI:
Roozbeh Tahmasebi
-
Assessment of Immune Status Against Measles, Mumps, and Rubella in Young Kuwaitis: MMR Vaccine Efficacy
Annual Meeting Abstract: J Virol Antivir Res
DOI:
Nada Madi, Haya Altawalah, Wadha Alfouzan, Widad Al-Nakib, Ebtihal Al-Roumi and Ahlam Jeragh
-
Marekâs Disease in Egyptian Turkeys: Molecular Characterization of the Causative Virus and A Novel Phylogentic Classification System
Annual Meeting Abstract: J Virol Antivir Res
DOI:
Haitham Amer, Mahmoud Bayoumi, Mohamed El-Saied and Magdy El-Mahdy
-
Advances in HIV Ag/Ab diagnosis: ALINITY vs ARCHITECT
Annual Meeting Abstract: J Virol Antivir Res
DOI:
Amani Elhouderi, Yvonne Obiajulu, Panagiotis Pantelidis and Graham Pickard
-
Use of edoxaban for the treatment of venous thromboembolism in HIV-infected patients
Annual Meeting Abstract: J Virol Antivir Res
DOI:
Alessandra Serrao
-
Potential of the Aptamers to fill therapeutic gaps to fight RNA viruses
Annual Meeting Abstract: J Virol Antivir Res
DOI:
Alfredo Berzal-Herranz and Cristina Romero-López
-
Virology & Antiviral Research 2020 Editorial Note
Editorial: J Virol Antivir Res
DOI:
Jared D Evans
-
Short Note on viral immunology
Short Communication: J Virol Antivir Res
DOI: 10.37532/2324-8955.2020.9(3)200
Mounica Merihelan*
-
Short Note on Viral Diseases
Short Communication: J Virol Antivir Res
DOI:
Mounica Merihelan*
-
Fishing Beyond the Peer: Future Omic Analyses of Virus-Host Interactions
Editorial: J Virol Antivir Res 2012, 1:1
DOI: 10.4172/2324-8955.1000e101
Andrea L. Kroeker, Alicia R. Berard and Kevin M. Coombs
-
Epidemiology and Molecular Characterization of Highly Pathogenic H5N1 Avian Influenza Viruses Isolated from Backyard Poultry
Research Article: J Virol Antivir Res 2017, 6:2
DOI: 10.4172/2324-8955.1000169
Maheswarappa Gowrakkal, Byregowda SM, Pradhan HK , Pattnaik B and Renukaprasad
-
Validation of Small Plasma Volume to Monitor HIV-1 Viral Load by Reverse Transcriptase Enzyme Activity Assay
Research Article: J Virol Antivir Res 2016, 5:3
DOI: 10.4172/2324-8955.1000156
Tran CT, Nguyen TN, Khuc TRH, Nguyen TKC and M Larsson
-
Prevention of Cervical Cancer in Women: Human Papillomavirus DNA Testing in Atypical Pap Smears
Research Article: J Virol Antivir Res 2013, 2:1
DOI: 10.4172/2324-8955.1000104
Massimo Origoni, Guia Carminati, Chiara Gelardi, Francesca Occhi and Chiara Stefani
-
Cathepsin B Plays a Key Role in Optimal Production of the Influenza A- Virus
Research Article: J Virol Antivir Res 2018, 7:1
DOI: 10.4172/2324-8955.1000178
Macon D Coleman, Soon-Duck Ha, Mansour Haeryfar, Stephen Dominic Barr and Sung Ouk Kim
-
Variability and Signatures of Capsid Amino Acid of HIV-1D Subtype from Drug-Naive and ARV-treated Individuals
Research Article: J Virol Antivir Res 2016, 5:1
DOI: 10.4172/2324-8955.1000148
Salvatore Dimonte and Muhammed Babakir-Mina
-
Study on Etiology of Viral Lower Respiratory Tract Infections in Children Under 10 Years of Age
Research Article: J Virol Antivir Res 2016, 5:4
DOI: 10.4172/2324-8955.1000160
Saadiya Khalid, Eijaz Ghani and Muhammad Ayyub
-
Occult Hepatitis B among Patients under Hemodialysis at Mansoura University Hospitals: Prevalence and Risk Factors
Research Article: J Virol Antivir Res 2014, 3:1
DOI: 10.4172/2324-8955.1000118
Maysaa El Sayed Zaki, Douaa Rafaat, Ahmed Eliwa and Mostafa Abdelsalam
-
Correlation between the HBsAg Level and the Peripheral Blood Lymphocytes Profile in Chronic Hepatitis B Patients from Malaysia
Research Article: J Virol Antivir Res 2016, 5:2
DOI: 10.4172/2324-8955.1000152
Qabas Neamah Hadi, Mohammed Imad Al-Deen Mustafa, Khairul Azhar Jaafar, Hui Yee Chee
-
Early Treatment of Influenza by Combination Drug Therapy
Editorial: J Virol Antivir Res 2012, 1:2
DOI: 10.4172/2324-8955.1000e106
E. Bart Tarbet
-
Bee Viruses: An Emerging Problem That Need BetterDiagnosis, Prevention and Control Strategies
Editorial: J Virol Antivir Res
DOI: 10.4172/2324-8955.1000e108
Guillermo H Sguazza and Francisco J Reynaldi
-
Detection of Rotavirus G3P[22]Genotype in Gnotobiotic Rabbit Model
Research Article: J Virol Antivir Res 2013, 2:3
DOI: 10.4172/2324-8955.1000112
Audrey Cilli, Claudia M Koike, Neuza M Frazatti-Gallina and Maria do Carmo Sampaio Tavares Timenetsky
-
Effect of Extracts of Passiflora edulis Leaves on Herpes Viruses Infection
Research Article: J Virol Antivir Res 2013, 2:2
DOI: 10.4172/2324-8955.1000108
Azhar Jabareen, Mahmoud Huleihil and Mahmoud Huleihel
-
Hepatitis B Virus Cellular Entrys Erecting a Barrier
Editorial: J Virol Antivir Res 2012, 1:1
DOI: 10.4172/2324-8955.1000e102
Pamela A. Norton
-
Human MicroRNA-602 Inhibits Hepatitis C Virus Genotype 1b Infection and Promotes Tumor Suppressor Gene Expression in a Hepatoma Cell Line
Research Article: J Virol Antivir Res 2016, 5:2
DOI: 10.4172/2324-8955.1000153
Samina Noorali, Kareem R Altidor, Samuel Emelife, Iqbal Mahmud, Raquel S White and Randall H Harris
-
Assessment of Natural Killer Cell Subsets in HCV Infection and Hepatocellular Carcinoma
Research Article: J Virol Antivir Res 2017, 6:2
DOI: 10.4172/2324-8955.1000170
Said S El-Feky, Mahmoud Abd-Elmongy , Hanady Y Hammad and Hanan H Fuaad
-
Platelets as a Possible Reservoir of HCV And Predictor of Response to Treatment
Research Article: J Virol Antivir Res 2016, 5:3
DOI: 10.4172/2324-8955.1000157
Aliaa Amer, Marawan Abu Madi, Fatma M Shebl, Dekra Al Faridi, Moza Alkhinji and Moutaz Derbala
-
Towards a West Nile Virus Vaccine
Review Article: J Virol Antivir Res 2012, 1:2
DOI: 10.4172/2324-8955.1000101
Jared D Evans
-
Anti-Rotaviral Effects of Calliandra haematocephala Leaf Extracts In-vitro and In-vivo
Research Article: J Virol Antivir Res 2015, 4:2
DOI: 10.4172/2324-8955.1000137
Mohamed Shaheen , Samy Mostafa and Nagwa El-Esnawy
-
Nanoparticle Vaccine for Avian Influenza Virus: A Challenge Study against Highly Pathogenic H5N2 Subtype
Research Article: J Virol Antivir Res 2018, 7:1
DOI: 10.4172/2324-8955.1000179
Jianping Li, Zeinab Helal, Brian Ladman,Christopher Karch, Jack Gelb , Peter Burkhard and Mazhar I Khan
-
Adefovir plus Entecavir Therapy in Chronic Hepatitis B Patients with Treatment Failure to Lamivudine-Entecavir Sequential Therapy: Outcome at 2 Years
Research Article: J Virol Antivir Res 2016, 5:1
DOI: 10.4172/2324-8955.1000149
Jong Won Choi, Se Hyun Kim, Jeong Hun Suh, Yong Suk Cho, Sun Young Won, Byung Kyu Park, Han Ho Cheon and Chun Kyon Lee
-
Effect of Different Routes of Inoculation on Plant-Derived VP2 Immunogenicity and Ability to Confer Protection Against Infectious Bursal Disease
Research Article: J Virol Antivir Res 2016, 5:4
DOI: 10.4172/2324-8955.1000161
María Soledad Lucero, Evangelina Gomez, Matías Richetta, Silvina Chimeno Zoth,Juan Manuel Carballeda, María José Gravisaco, Fernando Delgado and Analía Berinstein
-
Prevalence of Hepatitis Virus and HBV/HCV Interactions in Opiate Addict Subjects
Research Article: J Virol Antivir Res 2013, 2:4
DOI: 10.4172/2324-8955.1000115
Fabio Curcio and Clara Baldassarre
-
Response-Guided Peginterferon α-2a Monotherapy for Hemodialysis Patients with Chronic Hepatitis C
Research Article: J Virol Antivir Res 2014, 3:1
DOI: 10.4172/2324-8955.1000119
Kenjiro Yamakawa, Sawako Kobayashi Uchida, Tomoyuki Yamakawa, Akihiro Tamori and Norifumi Kawada
-
HIV Treatment with Once-Daily Single Tablet Regimens
Commentary: J Virol Antivir Res 2013, 2:1
DOI: 10.4172/2324-8955.1000105
Selcuk Kaya
-
Enhanced Fitness of Non-Pathogenic SHIV-NM-3rN Over Acute Pathogenic 89.6P in a Dual Infection/Compitition Assay on HSC-F Monkey Derived Cell Line
Research Article: J Virol Antivir Res 2013, 2:3
DOI: 10.4172/2324-8955.1000113
Kwofie Theophilus Benjamin and Miura Tomoyuki
-
Plant Derived Antivirals: A Potential Source of Drug Development
Review Article: J Virol Antivir Res 2013, 2:2
DOI: 10.4172/2324-8955.1000109
Mishra KP, Navita Sharma, Drishya Diwaker, Lilly Ganju and Singh SB
-
Viral Interferon Antagonism: Making the Leap from the Bench to the Clinic
Editorial: J Virol Antivir Res 2012, 1:1
DOI: 10.4172/2324-8955.1000e103
Gregory W. Moseley
-
Development of an Indirect-Elisa to Detect Antibodies against Porcine Reproductive and Respiratory Syndrome Virus Nucleocapsid Protein in Gansu China
Research Article: J Virol Antivir Res 2016, 5:2
DOI: 10.4172/2324-8955.1000154
Xiao-yuan Ma, Ying Qin, Yao-zhong Ding, Jie Zhang and Yong-guang Zhang
-
Case Study of Viral Hepatitis Based on Immigration Situation with Summary Review
Review Article: J Virol Antivir Res 2017, 6:2
DOI: 10.4172/2324-8955.1000171
Nawar Jasim Hussein and Mikhailov Mikhail Ivanovich
-
Diversity of and Implications from the Viral Genomes and Viral Proteins of Zika Virus
Short Communication: J Virol Antivir Res 2016, 5:3
DOI: 10.4172/2324-8955.1000158
Hong Cai, Min-Hua Luo, Yufeng Wang* and Qiyi Tang*
-
Role of Coatomer Protein I in Virus Replication
Review Article: J Virol Antivir Res 2012, 1:2
DOI: 10.4172/2324-8955.1000102
Jennifer A Thompson and Jay C Brown
-
Antigenic Complementarity between Influenza A Virus and Haemophilus influenzae may Drive Lethal Co-Infection Such as that Seen in 1918-19 Pandemic
Research Article: J Virol Antivir Res 2013, 2:1
DOI: 10.4172/2324-8955.1000106
Robert Root-Bernstein, Abigail Podufaly and Francesco Aimone
-
Knowledge of Hepatitis C and Awareness of Infection in the Egyptian Community
Research Article: J Virol Antivir Res
DOI: 10.4172/2324-8955.1000150
Engy Mohamed El-Ghitany, Azza Galal Farghaly and Ekram Wassim Abd El- Wahab
-
Identification of Inhibitors Binding Site of Ebola L Polymerase Based on its Homology Model
Short Communication: J Virol Antivir Res 2016, 5:4
DOI: 10.4172/2324-8955.1000162
Alfonso Trezza, Andrea Bernini and Ottavia Spiga
-
Herpes Simplex Virus Type-2 Infection and Associated Risk Factors among Weaver's Community in Tamil Nadu State, India
Research Article: J Virol Antivir Res 2013, 2:4
DOI: 10.4172/2324-8955.1000116
Sripriya M, Rajendran P, Seethalakshmi I, Murugesan K, Gnanasekaran AG, Kannan M and Kanthesh BM
-
Comparison of Real-Time RTPCR Assay with Direct Sequencing for Detection of Sensitivity or Resistant to Oseltamivir in Influenza A/H3N2 Viruses
Research Article: J Virol Antivir Res 2014, 3:1
DOI: 10.4172/2324-8955.1000120
Mohammad Hadi Karbalaie Niya, Jila Yavarian, Nazanin Zahra Shafiei Jandaghi, Shohreh Shahmahmoodi and Talat Mokhtari Azad
-
First Report of a Tomato yellow leaf curl virus Isolate Most Closely Related to a Previously Reported Begomovirus in Iran-Associated with Symptomatic Papaya Trees in Oman
Short Communication: J Virol Antivir Res 2018, 7:1
DOI: 10.4172/2324-8955.1000180
Haq QMI, Naureen Z, Mabood F, Brown JK, Al-Harrasi A, Al-Rawahi A, Gilani SA, Hussain J, Al-Sabari RSM, Al-Khanbashi FHS, Al-Fahdi AAM, Al-Zaabi AKA and Al-Shuraiqi FAM
-
Cordycepin an Adenosine Analogue Executes Anti Rotaviral Effect by Stimulating Induction of Type I Interferon
Research Article: J Virol Antivir Res
DOI: 10.4172/2324-8955.1000138
Shampa Deb Chanda, Anindyajit Banerjee, Satabdi Nandi, Saikat Chakrabarti and Mamta Chawla Sarkar
-
Phospholipase A2 Crotoxin B Isolated from the Venom of Crotalus durissus terrificus Exert Antiviral Effect against Dengue Virus and Yellow Fever Virus through Its Catalytic Activity
Research Article: J Virol Antivir Res 2014, 3:1
DOI: 10.4172/2324-8955.1000121
Raquel Rinaldi Russo, Vanessa Danielle Menjon M�ller, Adelia Cristina Oliveira Cintra, Luiz Tadeu Moraes Figueiredo, Suely Vilela Sampaio and Victor Hugo Aquino
-
Implications for Hepatitis C Treatment and Disease Progression in an HIV/HCV Co-Infected Population
Research Article: J Virol Antivir Res 2013, 2:3
DOI: 10.4172/2324-8955.1000114
Mackenzie Cottrell, R Chris Rathbun, Ryan Webb, Pete Johnson and Staci M Lockhart
-
Vitamin D Levels in an HIV Infected and Uninfected Cohort in New York City
Research Article: J Virol Antivir Res 2013, 2:2
DOI: 10.4172/2324-8955.1000110
Glenn S Turett, Simcha Pollack, Jarette B Seligman and David L Kaufman
-
Alternative Roles of Neuraminidase in Influenza a Viral Propagation
Editorial: J Virol Antivir Res 2012, 1:1
DOI: 10.4172/2324-8955.1000e104
Tracey M. Doyle and Sean (Xuguang) Li
-
Assessment of T-Cell Immunoregulatory Cytokine Patterns for Liver Fibrosis in Chronic Hepatitis B Patients Before and After Interferon Therapy
Research Article: J Virol Antivir Res 2016, 5:1
DOI: 10.4172/2324-8955.1000151
Rakesh Kumar Shrivastava, Sourav Sen and Praharaj AK
-
Prevalence of Hepatitis A virus in Bulgaria
Short Communication: J Virol Antivir Res
DOI: 10.4172/2324-8955.1000139
Kevorkyan A, Raycheva R, Markova E, Presti ALo and Angeletti S
-
DNA Zip Codes in Herpesvirus Genomes
Research Article: J Virol Antivir Res 2016, 5:2
DOI: 10.4172/2324-8955.1000155
Jay C Brown
-
Is it the Lower Respiratory Tract a Real Replication Site for KI Polyomavirus?
Research Article: J Virol Antivir Res 2012, 1:2
DOI: 10.4172/2324-8955.1000103
Muhammed Babakir-Mina
-
On the Existence of Animal Viroids
Rapid Communication: J Virol Antivir Res 2016, 5:4
DOI: 10.4172/2324-8955.1000163
Theodor O Diener
-
Efficacy of Virus Inhibitory Agent (VIA), Isolated from Host Plants Treated with Purified Clerodendrum aculeatum Phytoprotein Alone and in Combination with Bioenhancers
Research Article: J Virol Antivir Res 2017, 6:2
DOI: 10.4172/2324-8955.1000172
Awasthi LP, Ahmad Najam and Verma HN
-
HIV/AIDS in Africa: Trends, Missing Links and the Way Forward
Review Article: J Virol Antivir Res 2013, 2:1
DOI: 10.4172/2324-8955.1000107
Duri Kerina and Stray-Pedersen Babill
-
A Possible Mechanism of Action for the Inhibition of Plant Viruses by an Antiviral Glycoprotein Isolated From Boerhaavia diffusa Roots
Research Article: J Virol Antivir Res 2016, 5:3
DOI: 10.4172/2324-8955.1000159
Awasthi LP, Verma HN and Kluge S
-
To Treat or Not to Treat? : A Case of Severe Acute Hepatitis-B Treated with Entecavir Compared to a Case of Milder, Untreated Disease
Case Report: J Virol Antivir Res 2013, 2:4
DOI: 10.4172/2324-8955.1000117
Maria Francesca Zenobii, Stefano Ballestri, Amedeo Lonardo, Silvia Ognibene, Enrica Baldelli, Dante Romagnoli and Paola Loria
-
Treatment of Hepatitis C Virus Infection with Sovaldi Drug among Patients in Sohag Government, Egypt
Research Article: J Virol Antivir Res 2018, 7:1
DOI: 10.4172/2324-8955.1000181
El-Adly AM, Rashed LA, Yehia HM, Wardany AA, Shikhoun MH and Abdul-Raouf UM
-
HEV Parentral Transmission among Egyptian Children with Multiple Blood Transfusion
Research Article: J Virol Antivir Res 2014, 3:2
DOI: 10.4172/2324-8955.1000122
Ahmed Kamal Mansour, Maysaa El Sayed Zaki and Walaa Othman El Shabrawy
-
HIV Research Beyond the omics Era
Editorial: J Virol Antivir Res 2012, 1:1
DOI: 10.4172/2324-8955.1000e105
Michael Belshan
-
Antiviral Activity of 2-Nitromethyl Phenol, Zinc Nanoparticles and Seaweed Extract Against Cucumber mosaic virus (CMV) in Eggplant
Research Article: J Virol Antivir Res 2017, 6:2
DOI: 10.4172/2324-8955.1000173
Mohamed Mahmoud El-Sawy, Mohsen Mohamed Elsharkawy, Jehan Mohamed Abass and Mohamed Hassan Kasem
-
Ribavirin has an In vitro Antiviral Effect in Rabies Virus Infected Neuronal Cells but Fails to Provide Benefit in Experimental Rabies in Mice
Research Article: J Virol Antivir Res 2013, 2:2
DOI: 10.4172/2324-8955.1000111
Camila Michele Appolin�rio, Christophe Prehaud, Susan Dora Allendorf, Jo�o Marcelo Azevedo de Paula Antunes, Marina Gea Peres, Monique Lafon and Jane Megid
-
Multiple Mechanisms by which Retroviruses Cause Tumors: Can A Virus be Ruled Out if it Doesnât Fulfill One?
Research Article: J Virol Antivir Res 2018, 7:1
DOI: 10.4172/2324-8955.1000182
Gunzburg WH and Salmons B
-
HIV-1 RNA Quantification from Dried Blood Spots and Plasma Using the Siemens VERSANT HIV-1 RNA 1.0 Assay (kPCR)
Research Article: J Virol Antivir Res 2014, 3:2
DOI: 10.4172/2324-8955.1000123
Patricia Alvarez, Carmen Rodriguez, Leticia Martin, Jorge del Romero and Africa Holguin
-
Favorable Response in A Spanish Cohort of HIV Infected Men with Acute Hepatitis C Infection Who Received Delayed Antiviral Treatment
Research Article: J Virol Antivir Res 2014, 3:2
DOI: 10.4172/2324-8955.1000124
Montoya-Ferrer A, Gorgolas M, Garcia-Delgado R, Fierer DS and Fernandez-Guerrero ML
-
Treatment Response and Tolerability in Elderly Patients with Chronic Hepatitis C: Subgroup Analysis in ReGIT-J Study
Research Article: J Virol Antivir Res 2014, 3:2
DOI: 10.4172/2324-8955.1000125
Hiroki Nishikawa, Hirayuki Enomoto, Masaki Saito, Nobuhiro Aizawa, Yasuhiro Tsuda, Kazuhide Higuchi, Kazuichi Okazaki, Toshihito Seki, Soo Ryang Kim, Yasushi Hongo, Hisato Jyomura, Naoshi Nishida, Masatoshi Kudo, Yukio Osaki and Shuhei Nishiguchi